And frankly, we already do similar interventions, and we pay for similar interventions to the current model that we have that are high costs, with long term effects, with limited knowledge of what the long term impact is, and theyre high risk, and its for small patient populations
Myricetin: a dietary molecule with diverse biological activities
[Google Scholar] [Crossref] Handog E, Datuin M, Singzon I
Scenario 4: Already on GLP-1, considering adding HRT You are 50, have been on tirzepatide for 6 months with good weight loss (down 35 pounds), but are experiencing increasing menopausal symptoms including hot flashes, night sweats, vaginal dryness, and mood changes
Diagnostic tests, including ultrasound imaging of the gallbladder and liver function tests, can help determine the cause of the symptoms and guide appropriate treatment
Yes, with appropriate monitoring, as theres no direct interaction between semaglutide and DOACs